StockData
Capricor Therapeutics, Inc. logo

Capricor Therapeutics, Inc. (CAPR) stock

CAPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$8.41+0.11 (+1.33%)

Close on Nov 17, 2026Market cap $488.95MP/E –Yield –

Capricor Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Capricor Therapeutics's price to book ratio was 2.6× on Nov 11, 2026, against 2.9× a year earlier. Over the last 5 years it ranged from 0.8× to 61.1×, with a median of 6.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.6×−13.1
2025Dec 31, 202515.7×+7.6
2024Dec 31, 20248.2×−18.4
2023Oct 31, 202326.6×+20.4
2022Dec 30, 20226.2×+4.3
2021Dec 31, 20211.9×−0.4
2020Dec 31, 20202.3×+0.8
2019Dec 31, 20191.5×−0.3
2018Dec 31, 20181.8×−20.7
2016Jan 29, 201622.5×−3.4
2015Dec 31, 201525.9×+15.3
2013Apr 30, 201310.6×−64.2
2012Oct 31, 201274.7×−33.5
2011Dec 30, 2011108.3×–

More Capricor Therapeutics figures

See a number that looks wrong?